An Changhyeok, Choi In-Seon, Yao James C, Worah Samidha, Xie Keping, Mansfield Paul F, Ajani Jaffer A, Rashid Asif, Hamilton Stanley R, Wu Tsung-Teh
Department of Pathology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4096.
Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):656-63.
The influence of molecular characteristics in prognosis of gastric cancer remains unclear. The aim of this study was to evaluate the prognostic value of the CpG island methylator phenotype (CIMP) and microsatellite instability (MSI) in gastric cancer.
We studied the methylation profiles of tumor suppressor gene p16, DNA mismatch repair gene hMLH1, and four CpG islands (MINT1, MINT2, MINT25, and MINT31) using bisulfite/methylation-specific PCR, and MSI using five microsatellite markers in 83 resected gastric carcinomas. The CIMP and MSI status were compared with clinicopathologic features and overall survival.
Concordant methylation of multiple genes/loci (CIMP-high) was present in 31% of tumors and in 4% of non-neoplastic mucosa, CIMP-low in 55% and 17%, and CIMP-negative in 13% and 79%, respectively (P < 0.001). The prevalence of MSI-high, MSI-low, and MS-stable in tumor was 19%, 17%, and 64%, respectively. MSI status was closely associated with hMLH1 hypermethylation and CIMP status (P = 0.001). In univariate analysis, overall survival was predicted by pathologic stage (P < 0.0001), R0 resection (P = 0.0002), MINT31 methylation (P = 0.04), and CIMP-high status (P = 0.04). MSI status of tumor was not a significant predictor of prognosis. Although CIMP status seemed to be a prognostic predictor of gastric cancer, only pathologic stage remained a significant predictor of prognosis on multivariate analysis (P < 0.001).
Our results indicate that there is an association between CIMP status and MSI status in gastric cancer. Concordant methylation of multiple genes/loci (CIMP-H) is associated with better survival but is not an independent predictor of prognosis in resected gastric cancer.
分子特征对胃癌预后的影响仍不明确。本研究旨在评估CpG岛甲基化表型(CIMP)和微卫星不稳定性(MSI)在胃癌中的预后价值。
我们采用亚硫酸氢盐/甲基化特异性PCR研究了83例切除的胃癌中肿瘤抑制基因p16、DNA错配修复基因hMLH1以及四个CpG岛(MINT1、MINT2、MINT25和MINT31)的甲基化谱,并使用五个微卫星标记研究了MSI。将CIMP和MSI状态与临床病理特征及总生存期进行比较。
31%的肿瘤和4%的非肿瘤黏膜存在多个基因/位点的一致性甲基化(CIMP高),55%和17%为CIMP低,13%和79%为CIMP阴性(P<0.001)。肿瘤中MSI高、MSI低和MS稳定的发生率分别为19%、17%和64%。MSI状态与hMLH1高甲基化和CIMP状态密切相关(P = 0.001)。单因素分析中,总生存期可由病理分期(P<0.0001)、R0切除(P = 0.0002)、MINT31甲基化(P = 0.04)和CIMP高状态(P = 0.04)预测。肿瘤的MSI状态不是预后的显著预测指标。尽管CIMP状态似乎是胃癌预后的预测指标,但多因素分析中只有病理分期仍然是预后的显著预测指标(P<0.001)。
我们的结果表明胃癌中CIMP状态与MSI状态之间存在关联。多个基因/位点的一致性甲基化(CIMP-H)与更好的生存期相关,但不是切除胃癌预后的独立预测指标。